Acadia Pharmaceuticals Inc (ACAD)

Data delayed 15 minutes

Trading terms

Trading hours (UTC)
Isnin: 11:00 - 00:00
Selasa - Jumaat: 00:00 - 00:30, 11:00 - 00:00
Sabtu: 00:00 - 00:30

About

ACADIA Pharmaceuticals Inc. (ACADIA) is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines to address the medical needs in central nervous system disorders. The Company's lead product, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. ACADIA’s developments are focused on pimavanserin for additional neuropsychiatric conditions, trofinetide for Rett syndrome, ACP-044 for pain management and an early-stage muscarinic receptor program.

http://www.acadia-pharm.com/
х
Amaran risiko: Dagangan di pasaran kewangan membawa risiko.Nilai pelaburan boleh meningkat dan menurun dan pelabur mungkin kehilangan semua modal pelaburan mereka.Dalam kes produk yang dimanfaatkan, kerugian mungkin lebih daripada modal awal yang dilaburkan. Maklumat terperinci mengenai risiko yang berkaitan dengan perdagangan di pasaran kewangan boleh didapati dalam pendedahan risiko penuh.
Hubungi kamiTutup